131 related articles for article (PubMed ID: 20489042)
1. Insulin sensitivity and body composition in cirrhosis: changes after TIPS.
Holland-Fischer P; Nielsen MF; Vilstrup H; Tønner-Nielsen D; Mengel A; Schmitz O; Grønbaek H
Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G486-93. PubMed ID: 20489042
[TBL] [Abstract][Full Text] [Related]
2. Effect of transjugular intrahepatic portosystemic shunt on glycometabolism in cirrhosis patients.
Su AP; Cao SS; Le Tian B; Da Zhang Z; Hu WM; Zhang Y; Wang ZL; Babu SR; Hu T
Clin Res Hepatol Gastroenterol; 2012 Feb; 36(1):53-9. PubMed ID: 22099870
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone, insulin-like growth factor-1 and insulin resistance in cirrhosis.
Shmueli E; Stewart M; Alberti KG; Record CO
Hepatology; 1994 Feb; 19(2):322-8. PubMed ID: 7904978
[TBL] [Abstract][Full Text] [Related]
4. Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.
Keller U; Müller R; Berger W
Horm Metab Res; 1986 Sep; 18(9):599-603. PubMed ID: 2946637
[TBL] [Abstract][Full Text] [Related]
5. Temporal changes in insulin sensitivity following the development of acute liver failure secondary to acetaminophen.
Clark SJ; Shojaee-Moradie F; Croos P; Seed PT; Umpleby AM; Wendon JA; Miell J
Hepatology; 2001 Jul; 34(1):109-15. PubMed ID: 11431740
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
[TBL] [Abstract][Full Text] [Related]
7. Glucose resistance contributes to diabetes mellitus in cirrhosis.
Petrides AS; Schulze-Berge D; Vogt C; Matthews DE; Strohmeyer G
Hepatology; 1993 Aug; 18(2):284-91. PubMed ID: 8340056
[TBL] [Abstract][Full Text] [Related]
8. Glucose kinetics and splanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects.
Kiwanuka E; Barazzoni R; Tessari P
Diabetes Nutr Metab; 2001 Dec; 14(6):315-24. PubMed ID: 11853363
[TBL] [Abstract][Full Text] [Related]
9. Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation.
Merli M; Leonetti F; Riggio O; Valeriano V; Ribaudo MC; Strati F; Tisone G; Casciani CU; Capocaccia L
Hepatology; 1999 Sep; 30(3):649-54. PubMed ID: 10462370
[TBL] [Abstract][Full Text] [Related]
10. The IGF system after insertion of a transjugular intrahepatic porto-systemic shunt in patients with liver cirrhosis.
Holland-Fischer P; Vilstrup H; Frystyk J; Nielsen DT; Flyvbjerg A; Grønbaek H
Eur J Endocrinol; 2009 Jun; 160(6):957-63. PubMed ID: 19336524
[TBL] [Abstract][Full Text] [Related]
11. [Effect of transjugular portosystemic shunt on insulin resistance].
Stefánková J; Safka V; Fejfar T; Hůlek P; Dresslerová I; Krajina A
Vnitr Lek; 2002 Nov; 48(11):1017-24. PubMed ID: 12577452
[TBL] [Abstract][Full Text] [Related]
12. Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis.
Lotterer E; Wengert A; Fleig WE
Hepatology; 1999 Mar; 29(3):632-9. PubMed ID: 10051460
[TBL] [Abstract][Full Text] [Related]
13. Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation.
Tietge UJ; Selberg O; Kreter A; Bahr MJ; Pirlich M; Burchert W; Müller MJ; Manns MP; Böker KH
Liver Transpl; 2004 Aug; 10(8):1030-40. PubMed ID: 15390330
[TBL] [Abstract][Full Text] [Related]
14. The effect of pioglitazone on the liver: role of adiponectin.
Gastaldelli A; Miyazaki Y; Mahankali A; Berria R; Pettiti M; Buzzigoli E; Ferrannini E; DeFronzo RA
Diabetes Care; 2006 Oct; 29(10):2275-81. PubMed ID: 17003306
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity.
Petrides AS; Stanley T; Matthews DE; Vogt C; Bush AJ; Lambeth H
Hepatology; 1998 Jul; 28(1):141-9. PubMed ID: 9657106
[TBL] [Abstract][Full Text] [Related]
16. Changes in adipokines after transjugular intrahepatic porto-systemic shunt indicate an anabolic shift in metabolism.
Thomsen KL; Sandahl TD; Holland-Fischer P; Jessen N; Frystyk J; Flyvbjerg A; Grønbæk H; Vilstrup H
Clin Nutr; 2012 Dec; 31(6):940-5. PubMed ID: 22541535
[TBL] [Abstract][Full Text] [Related]
17. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
[TBL] [Abstract][Full Text] [Related]
18. The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy.
Rosenfalck AM; Fisker S; Hilsted J; Dinesen B; Vølund A; Jørgensen JO; Christiansen JS; Madsbad S
Growth Horm IGF Res; 1999 Apr; 9(2):96-105. PubMed ID: 10373342
[TBL] [Abstract][Full Text] [Related]
19. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
[TBL] [Abstract][Full Text] [Related]
20. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
